USPatentGranted

Phospholipid modified non-thombogenic surface

Granted 17 Sep 1996 · no office action yet

Current assignee: Regents of the University of Minnesota · originally University Of Minnesota

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Daniel L. Mooradian, Anja S. Kohler, Leo T. Furcht · Examiner: Carlos Azpuru

Application
406124
filed 17 Mar 1995
Publication
Not published
not published
Patent· this page
US 5,556,632
granted 17 Sep 1996

Life of the patent

2 dated events
⤢ drag to zoomApr 1995Jul 1995Oct 1995Jan 1996Apr 1996Jul 1996Oct 1996Prosecution
Prosecutionhover for detail · click to open

Abstract

A biocompatible material comprising a substrate and a phospholipid moiety covalently attached thereto in an amount and orientation effective to provide an improved nonthrombogenic surface relative to the substrate without the phospholipid moiety covalently attached thereto is provided. In particularly preferred embodiments, the biocompatible material has the following structure: ##STR1## wherein: R.sup.1 is a (C.sub.1 -C.sub.30)alkyl group; R.sup.2 is a (C.sub.1 -C.sub.30)alkylene group; m is 1-4; n is 1-4; and L is a divalent linking group covalently bonded to the substrate and to the phospholipid moiety.

Claims

19 · 3 independent · depth 6
12345678910111213141516171819
19 granted claims

Classifications

3 codes
USPC · US Patent Classification
424/423523/112.113,514/822

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
1.5 y
550 days filing → grant
Office actions
0
on the grant's record
Examiner
Carlos Azpuru
art unit —
Citations: 19 back · 0 forward

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock